BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 23665256)

  • 1. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
    Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
    J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction.
    O'Sullivan JF; Leblond AL; Kelly G; Kumar AH; Metharom P; Büneker CK; Alizadeh-Vikali N; Hristova I; Hynes BG; O'Connor R; Caplice NM
    Circ Cardiovasc Interv; 2011 Aug; 4(4):327-35. PubMed ID: 21712526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction.
    Qi Q; Lu L; Li H; Yuan Z; Chen G; Lin M; Ruan Z; Ye X; Xiao Z; Zhao Q
    Int J Nanomedicine; 2017; 12():4835-4848. PubMed ID: 28744119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent endothelial progenitor cell-conditioned media-related anti-apoptotic, cardiotrophic, and pro-angiogenic effects post-myocardial infarction are mediated by insulin-like growth factor-1.
    Hynes B; Kumar AH; O'Sullivan J; Klein Buneker C; Leblond AL; Weiss S; Schmeckpeper J; Martin K; Caplice NM
    Eur Heart J; 2013 Mar; 34(10):782-9. PubMed ID: 22173909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin inhibits myocardial ischemia-induced apoptosis and alleviates chronic adverse changes in post-ischemic cardiac structure and function.
    Xing W; Yan W; Fu F; Jin Y; Ji L; Liu W; Wang L; Lv A; Duan Y; Zhang J; Zhang H; Gao F
    Apoptosis; 2009 Sep; 14(9):1050-60. PubMed ID: 19590963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model.
    Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K
    PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
    Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
    PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure.
    Cittadini A; Monti MG; Petrillo V; Esposito G; Imparato G; Luciani A; Urciuolo F; Bobbio E; Natale CF; Saccà L; Netti PA
    Eur J Heart Fail; 2011 Dec; 13(12):1264-74. PubMed ID: 22045926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone mediates cardioprotection against postinfarction remodeling and dysfunction through the IGF-1/PI3K/AKT signaling pathway.
    Zeng B; Liao X; Liu L; Zhang C; Ruan H; Yang B
    Life Sci; 2021 Feb; 267():118977. PubMed ID: 33383053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
    Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
    Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
    Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction.
    Ruvinov E; Leor J; Cohen S
    Biomaterials; 2011 Jan; 32(2):565-78. PubMed ID: 20889201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
    Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
    Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional benefits of PLGA particulates carrying VEGF and CoQ10 in an animal of myocardial ischemia.
    Simón-Yarza T; Tamayo E; Benavides C; Lana H; Formiga FR; Grama CN; Ortiz-de-Solorzano C; Kumar MN; Prosper F; Blanco-Prieto MJ
    Int J Pharm; 2013 Oct; 454(2):784-90. PubMed ID: 23639291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
    J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
    Zhang KR; Liu HT; Zhang HF; Zhang QJ; Li QX; Yu QJ; Guo WY; Wang HC; Gao F
    Apoptosis; 2007 Sep; 12(9):1579-88. PubMed ID: 17505785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
    Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
    Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.